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Sub-optimal nutrition during pregnancy has been shown to have long-term effects on the health of off-
spring in both humans and animals. The most common outcomes of such programming are hypertension,
obesity, dyslipidaemia and insulin resistance. This spectrum of disorders, collectively known as metabolic
syndrome, appears to be the consequence of nutritional insult during early development, irrespective of
the nutritional stress experienced. For example, diets low in protein diet, high in fat, or deﬁcient in iron
are all associated with programming of cardiovascular and metabolic disorders when fed during rat preg-
nancy. In this paper, we hypothesise that the nutritional stresses act on genes or gene pathways common
to all of the insults. We have termed these genes and/or gene pathways the ‘‘gatekeepers’’ and hence
developed the ‘‘gatekeeper hypothesis’’. In this paper, we examine the background to the hypothesis
and postulate some possible mechanisms or pathways that may constitute programming gatekeepers.
 2011 Elsevier Ltd. Open access under CC BY license.The theory of programming
During pregnancy, the developing fetus is entirely dependent
on its mother for nutritional requirements. It is axiomatic, there-
fore, that maternal nutrition will have a very important role to play
in growth, development and pregnancy outcome. This role extends
beyond the fetal and neonatal periods and into adult life. Many
studies, in both humans and animals, have demonstrated that
sub-optimal nutrition during pregnancy can have marked conse-
quences for the offspring, even as an adult. These observations
led to a hypothesis known as the ‘‘fetal programming’’ hypothesis
[1]. Programming may be deﬁned as the response made by an
organism to an insult or stimulus occurring during a critical period
of development. As developmental processes occur in a deﬁned se-
quence, adaptations that occur in response to external signals dur-
ing phases of growth or maturation will generally be irreversible.
Hence the environment can have a permanent impact on physiol-
ogy and long-term health and well-being.Evidence from epidemiological studies
The basis for the fetal programming hypothesis was a series of
retrospective cohort studies considering the health of men and
women born in the early part of the twentieth century, in the
UK, Finland and Sweden. Originally, the data suggested that the; fax: +44 (0) 1224 715349.
le).
Y license.link was primarily with weight at birth, as numerous studies de-
scribed the association between low birth weight and cardiovascu-
lar morbidity and mortality [2–5]. Critically, this association was
seen within the normal range of birth weight, not just in infants
that are born small [6]. Barker’s Hertfordshire cohort, a UK popula-
tion born between 1910 and 1930, for example showed graded and
linear relationships between birth weight and coronary heart dis-
ease death, blood pressure, type 2 diabetes and the metabolic syn-
drome [2,4,7,8].
More recently it has been suggested that other parameters may
also be relevant in determining risk of disease in the offspring. The
most robust of these may be the ratio between the placenta and
the newborn infant, which gives an indication of placental efﬁ-
ciency [9]. A large US cohort study demonstrated that a high pla-
cental-to-birth weight ratio, but not birth weight itself, was
associated with high blood pressure in childhood [10]. Similarly,
a Norwegian cohort study showed a positive association between
placental-to-birth weight ratio and cardiovascular disease [11].
Evidence also suggests that growth in the ﬁrst year of extra-uterine
life is important. A number of systematic reviews have supported
the concept that increased growth rate in early life is a risk factor
for subsequent obesity. Upwards crossing of centiles for weight
and length in infancy is associated with later obesity risk [12,13]
and it has been estimated that 20% of the risk of obesity at 7 years
of age can be attributed to being in the highest quintile for weight
gain over the ﬁrst 4 months of life [14]. Studies of adults born in
Helsinki in the ﬁrst half of the twentieth century suggest that indi-
viduals who go onto suffer from coronary heart disease were
smaller at birth but gained weight rapidly in childhood [3]. While
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risk of non-communicable disease in adult life, the overall impact
of programming will be dependent upon other risk factors. For
example, other work indicates that there are interactions between
early life factors and adult lifestyle, with the greatest risk of meta-
bolic disorders associated with relative thinness at birth and obes-
ity in adulthood [15]. In addition to these interactions between
early environment and adult risk factors, programming inﬂuences
appear to interact with genotype. For example, it is reported that
there is an interaction of the pro12ala polymorphism of PPAR
c-2, with markers of prenatal growth, in determining adult insulin
sensitivity, cholesterol metabolism and risk of cardiovascular dis-
ease. The Ala12 allele is associated with signiﬁcantly lower fasting
insulin and HOMA-IR index, but this beneﬁcial effect of the poly-
morphism is isolated to individuals who were of lower weight at
birth [16].Evidence from animal models
While such epidemiological studies have played a key role in
highlighting the associations between early life events and later
disease, they are limited in their ability to identify the causal fac-
tors that underpin early life programming and have been fre-
quently criticised on the basis of inadequate adjustment for
confounding factors and inconsistent study designs, outcomes
and interpretation [17]. Experimental studies using animals have
played a critical role in demonstrating the biological plausibility
of the fetal programming hypothesis and are now being used to
examine the mechanistic drivers of such programming. Evidence
of prenatal programming of adult physiological function and dis-
ease by maternal nutritional status has been demonstrated and
replicated using a broad range of animal models.
Animal studies that have investigated the early life program-
ming of adult cardiovascular disease have used maternal dietary
manipulations to inﬂuence fetal growth. It is consistently noted
in rats [18,19], mice [20] and guinea pigs [21] that fetal exposure
to undernutrition produces elevated blood pressure. Similar obser-
vations in large animal species such as the sheep [22,23], suggest
that programming of cardiovascular function occurs in all mam-
mals. The nature of the nutritional insult does not appear to be spe-
ciﬁc as it is noted that imposing a wide variety of nutritional and
environmental stressors during pregnancy produces the same gen-
eral phenotypic outcomes in the offspring. Hypertension is noted
in the offspring of rodents exposed to maternal food restriction
[19], protein restriction [24], iron deﬁciency [25], high fat feeding
[26], uterine artery ligation [27] and dexamethasone treatment
[28]. The same range of maternal treatments is also associated
with impaired glucose homeostasis, renal impairments and meta-
bolic disturbance in the offspring.The thrifty phenotype hypothesis
Following thedevelopment of the fetal programminghypothesis,
the ‘‘thrifty phenotype’’ hypothesis was proposed by Hales and
Barker [29]. This argued that development in utero is regulated in
a waywhich sets themetabolism of the developing fetus to be opti-
mal within a certain postnatal nutritional environment. The thrifty
phenotype hypothesis proposed that fetal exposure to undernutri-
tion resulted in metabolic adaptation that encouraged efﬁcient
(thrifty) utilization of scarce energy substrates. If the same nutrient-
or energy-poor environment prevailed in the postnatal period, then
the individualmay be conferredwithmetabolic advantage. Difﬁcul-
ties would arise if the postnatal nutritional environment did not
match the fetal environment (i.e. relative excess of energy andnutri-
ents in the postnatal period), as the individual would be irreversiblymaladapted for such conditions. This hypothesis was initially pro-
posed to explain the development of insulin resistance [29] but
has since been extrapolated to other aspects ofmetabolic syndrome.
Whether this extension is justiﬁed is not completely clear.
One such population where this hypothesis was tested was the
group of Ethiopian Jews (Falasha) who migrated from the Gondar
region of Ethiopia to Israel in the 1980s. Cohen and colleagues
[30] ﬁrst reported that among young Ethiopian-born men who
had been living in Israel for less than 4 years, there had been a ma-
jor shift in dietary habits. Rather that consuming a diet based upon
the Ethiopian injura bread and spicy stews, the Falasha migrants
took on a westernized diet rich in reﬁned carbohydrate sources.
Remarkably the prevalence rates for diabetes in this population
soared to 18%, some 30-fold higher than among the original
Ethiopian population and 2-fold higher than among other ethnic
groups in Israel. It could be argued that this shift demonstrates
the thrifty phenotype in action. The Falasha migrants while in utero
would have developed in an environment of scarce resource, and
whilst remaining in their environment their acquired metabolic
thrift would have been advantageous. The shift to the Israeli pat-
tern of diet, however, brought out the negative consequences of
that thrift. An alternative explanation is that the Falasha carry a
genotype that promotes diabetes, but only when individuals are
exposed to a diabetogenic environment [31].
In animal models, alterations in glucose homeostasis and insu-
lin sensitivity which occur in response to prenatal undernutrition
appear to ﬁt with this theory. For example, offspring of the uterine
ligation model exhibit reduced beta cell mass [32] and relative
hyperglycaemia [33]. Maternal calorie restriction also leads to
hyperinsulinaemia in adulthood in the rat [34].
The thrifty phenotype hypothesis has been developed further to
suggest that it is only one of a series of adaptations that occur dur-
ing development to a predicted external environment. The ‘‘predic-
tive adaptive response’’ theory argues that there are selective
advantages in predicting the environment into which an animal
will be born and preparing appropriately [35]. Using examples
from developmental zoology, the authors of this paper propose
that plasticity in response to nutrition is only one of a series of
modiﬁcations that can be, and are, made. For example, voles will
have different degrees of fur covering at birth depending on the
time of year they are born [36].
The thrifty phenotype hypothesis and the predictive adaptive
response theory appear to ﬁt with many observations from epide-
miology and animal experiments. However, there are clear exam-
ples of studies where they cannot explain observed consequences
of variation in maternal nutrition. The main thrust of these hypoth-
eses is that disease is the consequence of a mismatch between fetal
and postnatal environments. However, it is clear that in the case of
animals exposed to maternal high fat feeding or obesity, the
‘‘match’’ of environments whereby the animals are also weaned
onto a high fat, obesogenic diet, produces the most detrimental ef-
fect on health [37–39].The response to intrauterine insult: mechanisms of
programming
All of the hypotheses outlined above have considerable value.
They are all testable and also imply ways of alleviating the prob-
lems caused by suboptimal intrauterine nutrition. However, they
do not suggest possible mechanisms whereby the phenotype is
generated. They also do not explain why, even though the stresses
imposed are of many different types, the phenotype that is gener-
ated is remarkably similar.
The majority of programming manifests itself as many of the
constituent parts of the metabolic syndrome, characterised by
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spective of the stress, whether it is low protein, low iron, high fat
or some other effector, the offspring manifest at least three of
the four symptoms. Within the current theoretical frameworks it
is not clear why apparently diverse nutritional insults result in
the same common pattern of programmed responses. There are
two strands to consider in unravelling the mechanisms of pro-
gramming. Firstly it is important to understand the changes which
occur in the embryo, fetus or neonate at the time of the actual in-
sult as these will be the primary drivers of the programmed pheno-
type. Secondary to this there will be mechanistic changes which lie
on the main route from this initial response to compromised phys-
iological function and disease pathology. It is in this latter area that
the greatest concentration of experimental evidence from animal
studies has been focused.
The simplest explanation of nutritional programming relates to
altered organ and tissue structure, modifying the capability of or-
gans to perform normally. Organs develop from progenitor stem
cells, which have a strict order of growth and development. They
also grow at tightly speciﬁed times in development. Anything that
disrupts this order is very likely to have consequences [42], and in
the simplest scenarios will result in organs that are smaller, due to
a lower ﬁnal cell number, or which are morphologically altered due
to the presence of alternative cell types. This process has been
termed tissue remodelling [43]. The tissue remodelling phenome-
non has mostly been studied in kidney, by our group and others
[44,45]. Feeding a low protein diet during rat pregnancy, particu-
larly during the later stages of gestation, results in a kidney of nor-
mal size but with a reduced (up to 30%) complement of nephrons.
Similar observations have been made in sheep following maternal
food restriction during the major phase of nephrogenesis [23].
Most importantly, this remodelling aspect of programming has
also been suggested in human patients exhibiting symptoms of pri-
mary hypertension [46]. Although as yet not extensively investi-
gated, the brain [47], pancreas [48], hypothalamus [49], muscle
[50] and placenta [51–54] also show evidence of remodelling
which may affect organ function.
Relating the remodelled tissue morphology to tissue and organ
function and the capacity of the organ to maintain physiological
competence throughout the lifespan is a key component of being
able to explain how programming leads to disease. A reduction
in nephron number, for example, is proposed to be one of the driv-
ers of systemic hypertension. The nephron is the basic functional
unit of the kidney and with a lower nephron complement local
blood pressure has to be increased to maintain ﬁltration function.
Over time this leads to further nephron loss, glomerular injury [55]
and rising local blood pressure eventually manifests as systemic
hypertension. Similarly remodelling of neuronal densities in the
appetite regulation centres of the hypothalamus [49] may explain
how fetal exposure to maternal protein restriction impacts upon
feeding behaviours.
Evidence of programming of the hypothalamic control of feed-
ing provides an interesting perspective on other routes leading
from early insult to later disease. Remodelling of tissues with crit-
ical homeostatic functions could effectively ‘‘reset’’ aspects of
physiology, particularly if the affected tissues are endocrine organs
or if programming has impacted upon the cells which are the tar-
gets for endocrine signalling. The renin–angiotensin system is a
multi-organ system that regulates blood pressure and hyperten-
sion is one of the most common outcomes of nutritional program-
ming. The kidney secretes the enzyme renin, which cleaves the
liver produced angiotensinogen to produce angiotensin I (Ang I).
Ang I is further cleaved by angiontensinogen converting enzyme
(ACE), found primarily in the lung, leading to the formation of
angiotensin II (Ang II). Ang II regulates blood pressure by both
stimulating sodium transporters [56] and by increasing theproduction and release of aldosterone [57]. Offspring born to
mothers fed a low protein diet during pregnancy go onto develop
high blood pressure. We have shown that administration of ACE
inhibitors in early postnatal life decreased blood pressure in the
hypertensive animals [58]. When the ACE inhibitor treatment
was started as early as 2 weeks postnatally, the decrease in blood
pressure was maintained into adulthood, even in absence of inhib-
itor [59]. These results argued that the critical step for the nutri-
tional programming was the ANGII. Further weight was added to
this hypothesis when an antagonist of the ANGII receptor was
administered, giving a similar response [60].
The renin–angiotensin system is one component of a complex
network of systems which regulate blood pressure. The sympa-
thetic nervous system also plays a key role, with the hypothalamus
integrating signals from baro- and osmoreceptors with activity of
the renin–angiotensin system, peripheral vascular resistance and
renal function. There is a growing body of evidence to suggest that
many aspects of this layer of control are subject to programming
inﬂuences, with animals exposed to protein restriction, maternal
food restriction and high fat feeding in utero exhibiting altered
baroreceptor sensitivity [61], enhanced pressor responses to stress
[62] and vasoconstrictors [63].
The effects of nutritional insults on organ differentiation and
proliferation may not, of course, be directly mediated through
the relative deﬁciency or excess of substrates needed for growth,
or by direct nutrient–gene interactions. Nutrients may also impact
upon embryonic and fetal development through indirect modula-
tion of the endocrine cross-talk across the placenta. Glucocorti-
coids, for example, have a wide variety of functions during
pregnancy, including promoting both proliferation and differentia-
tion. In pregnancy, there is a substantial gradient of glucocorticoids
across the placenta. The placenta converts glucocorticoids to their
inactive form by the enzyme 11b-hydroxysteroid dehydrogenase 2
(11bHSD2) [64], a function which is critical in allowing the fetus to
develop its own regulation of development. Anything that happens
to reduce 11ßHSD2 activity in the placenta can result in over-
exposure to glucocorticoids of maternal origin and hence inappro-
priate patterns of growth, gene expression and development in the
fetus. Work from our laboratory demonstrated that the feeding of a
low protein diet in rat pregnancy reduced placental activity of
11ßHSD by approximately one third [65] and also showed that car-
benoxolone, an inhibitor of 11ßHSD2, could mimic the effect of a
maternal low protein diet [66]. Programming of high blood pres-
sure by protein restriction is to some extent dependent on the
presence of maternal glucocorticoids as pharmacological ablation
of steroid synthesis using metyrapone negates the effects of nutri-
tional insult [18,67]. Others have treated rats with dexamethasone,
a poor substrate for 11ßHSD2, and generated hypertension and re-
nal defects in the offspring, which closely resemble the long-term
sequelae of maternal undernutrition [68].
High concentrations of fetal glucocorticoids can also alter activ-
ity of the hypothalamic–pituitary–adrenal (HPA) axis. The HPA axis
is regulated by a negative feedback system. Glucocorticoids re-
leased into the circulation by the adrenal gland interact with the
glucocorticoid receptors of the pituitary, hypothalamus and hippo-
campus. This in turn alters responses to glucocorticoids released in
future stress events. There is now evidence that exposure to excess
fetal glucocorticoids at critical periods of development can alter
the set point of the HPA axis leading to both altered basal and
stress-induced glucocorticoid responses postnatally in both ro-
dents and humans [69,70]. Studies of the long-term programming
effects of undernutrition suggest that this can have a similar effect.
Fetal exposure to maternal protein restriction results in a blunted
circadian proﬁle of ACTH secretion and is associated with program-
ming of glucocorticoid receptor expression in a variety of tissues
[71,72]. Moreover, in rats with hypertension programmed by a
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sure, whilst adrenalectomy with corticosterone replacement main-
tains higher pressure [73]. It is tempting to conclude that
disturbances of HPA axis function may help explain fetal program-
ming, particularly as such disturbances have long been associated
with obesity and insulin resistance [74].The epigenetic hypothesis
Each of the proposed mechanisms described above has merits,
but they do not explain what is happening on a molecular scale
or fully address what may be the primary response to an adverse
nutritional environment during development. It is not clear why,
for example, diverse forms of undernutrition result in remodelling
of the kidney, or why the same nutritional insults should bring
about changes in placental 11ßHSD2 activity. Recently, evidence
has been accumulating that nutritional deprivation can induce epi-
genetic changes, which in turn can programme the phenotype of
an individual.
Epigenetics describes the study of heritable changes in gene
expression that are not caused by changes in the primary DNA se-
quence [75]. The epigenetic code is a series of small marks added to
DNA or to histone proteins. There are currently two well deﬁned
mechanisms by which this epigenetic code can be created; the
addition of methyl groups to DNA cytosine bases and the post-
translational modiﬁcation of histone proteins by the addition of
methyl or acetyl groups [76]. Methylation or histone modiﬁcation
can determine whether or not genes can be expressed, and hence
generates additional ﬂexibility in the genetic code, allowing one
genotype to have a variety of phenotypes.
The epigenetic code, although heritable, is thought not to be
ﬁxed throughout the life stages. It is known that it is vulnerable
to alteration during several life stages, spanning embryogenesis,
fetal and neonatal development, puberty and old age [77,78]. There
is evidence that epigenetic drift occurs across the lifespan and this
can promote both DNA hypo- and hyper-methylation. The basis of
age-related epigenetic drift is that there is a progressive decline in
expression of DNA methyltransferase-1 (DNMT1), the enzyme
which maintains DNA methylation patterns set earlier in life. This
leads to passive demethylation of the whole genome. In some tis-
sues the response to this may be up-regulation of DNA methyl-
transferase-3b (DNMT3b), leading to hypermethylation of CpG
islands in speciﬁc gene promoters. This mechanism has been
shown to explain changes in gene expression in the development
of human cancers and Alzheimers disease. During gestation the
developing embryo/fetus is subject to both de-methylation and
re-methylation [79] and this may make an individual particularly
susceptible to environmental interference, including that of nutri-
tion as the process of methylation is dependent upon an adequate
supply of folates, choline and other B vitamins.
It is now well established that diets that are suboptimal in
nutrients directly involved in methyl-group metabolism can signif-
icantly alter the epigenetic code. Sinclair and colleagues demon-
strated that restriction of the maternal supply of B vitamins
during the periconceptual period in sheep could alter the methyl-
ation state of up to 4% of the whole genome. Even where methyl
donors are present in apparently normal concentrations, undernu-
trition can interfere with the setting of epigenetic marks [71,80–
82]. Two mechanisms are now proposed by which all nutritional,
and environmental factors, can alter the epigenetic code. Altera-
tions could be caused ﬁrstly by directly interfering with the pro-
cess of DNA or histone methylation by affecting the supply of
methyl donors in the diet, or the activity of the enzymes responsi-
ble for DNA methylation or histone modiﬁcations, such as acetyla-
tion and methylation.A second possible mechanism is by changing the amount of
DNA available for methylation by altering the transcriptional
activity of speciﬁc genes during times of DNA methylation [76].
Lillycrop and colleagues have demonstrated that the hepatic
expression of PPARa is up-regulated in young adult rats following
fetal exposure to maternal protein restriction. The increased gene
expression is associated with hypomethylation of the gene
promoter, altered expression of DNA methyltransferases and
modiﬁcation of histones. Similarly the adrenal expression of the
angiotensin type 1b receptor is up-regulated by maternal undernu-
trition, following hypomethylation of the promoter [83]. In the
latter case, the effect appears dependent upon the production of
maternal steroids during pregnancy, suggesting that there is some
effect of antenatal glucocorticoids upon the epigenome of the
developing fetus.
Although of major interest the epigenetic hypothesis leaves
many unanswered questions. For example, why does a low protein
diet have a speciﬁc effect on particular genes and particular tissues,
rather than affecting the whole of the epigenome? Which speciﬁc
component of a diet alters the epigenetic process? And, of course,
what are the speciﬁc steps in the process that result in changes in
epigenetic proﬁle? It is also important to note that resetting of epi-
genetic marks does not explain all of the observed programming
effects of nutritional stressors. Bogdarina and colleagues demon-
strated that in offspring of rats fed a low protein diet during preg-
nancy, the hepatic expression of glucokinase was down-regulated
in the absence of any changes in DNA methylation [84]. Moreover,
although there are a number of reports of maternal nutrition
impacting on DNA methylation and gene expression, none of the
speciﬁc genes described are known to be major candidate genes
for human disease processes. Despite their drawbacks, however,
epigenetic explanations are very tempting as the cause of program-
ming and it is possible that these underpin the phenotype we ob-
serve when development and nutrition intertwine. Given the
potential heritability of epigenetic changes occurring within germ
cells, this mechanism would also provide a useful explanation of
how certain effects of undernutrition during pregnancy can be
transmitted to more than one successive generation [85,86].The concept of the gatekeeper
Evidence to support the proposed mechanisms discussed above
has been provided by a large number of experimental studies. Each
of these studies has attempted to address the important aim of
identifying how nutritional signals during fetal development per-
manently alter organ structure and function, and hence promote
greater disease risk. However, all are essentially observational
studies and do not explain the commonality between models, in
particular the remarkable similarities between the effects of
maternal undernutrition and maternal over-feeding. As such, they
are unable to determine the common underlying mechanisms and
principles that drive programmed disease processes. Animal stud-
ies in this ﬁeld tend to characterise the downstream phenotypes
that are observed in adult offspring and hence focus on processes
that may mediate the exact pathology or metabolic consequences
of programming. Many of these processes are likely to be second-
ary phenomena and do not explain the basis of programming.
Broad assumptions have been drawn about observed changes in
expression of single genes or speciﬁc pathways that have been se-
lected on the basis of their plausible involvement in development
of metabolic or vascular phenotypes. Close association of gene
expression changes with the phenotype of interest actually in-
creases the likelihood that observed effects are secondary events.
Therefore it has to be recognised that the most likely drivers of
nutritional programming are still unknown.
Fig. 2. Proposed experimental design to test the gatekeeper hypothesis. The
gatekeeper hypothesis asserts that relatively few commonmechanisms will operate
to determine the common phenotypes that follow programming insults. Testing the
hypothesis therefore relies on the parallel study of two maternal dietary insults
which share a common phenotypic outcome in the offspring. Use of techniques
such as microarray or proteomics allows an unbiased and systematic approach to
identify the molecular targets of the maternal insults. Analysis of proteomic and
gene array data will identify core gatekeeper processes and pathways and provide
insight into the mechanisms which drive programming across different develop-
mental stages.
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carried out on experimental animals to try and understand how fe-
tal programming may occur, is the ﬁnding of remarkable similarity
between the phenotypes that arise in response to different mater-
nal insults. For example in rats, the feeding of low protein, high fat
or low iron diets in pregnancy all result in hypertension and rela-
tive obesity. This observation has given rise to what we are terming
the ‘‘gatekeeper hypothesis’’. The essence of this hypothesis is that
there are a limited number of genes or gene pathways that are
inﬂuenced by a nutritional insult and that changes to these core
biological processes represent the primary response to insult from
which all subsequent events leading to disease are derived.
The hypothesis can be represented graphically by the Venn dia-
gram shown in Fig 1. In essence, any nutritional stress will gener-
ate a complex set of responses. Some of these will be homeostatic,
occurring to reduce the impact of the nutritional stressor and to
maintain stores and levels of critical nutrients. Potentially these
responses could initiate the chain of events leading directly to
postnatal pathology, but the majority may have no lasting conse-
quence. Other responses will be pathological responses, occurring
as a consequence of, or themselves causing, damage related di-
rectly to the nutritional stressor.
The identiﬁcation of the gatekeeper processes represents a sig-
niﬁcant technical challenge, but the recent advances in proteomics
and nutrigenomics puts this within the grasp of researchers in this
ﬁeld. The experimental approach that we propose (Fig. 2) involves
the parallel application of two nutritional insults known to pro-
gramme a common phenotype, such as high blood pressure, during
rat pregnancy and the collection of embryonic or fetal material.
Preparation of samples for proteomic and microarray analysis
would generate a wealth of data from which pathway analysis
would identify the genes, proteins and processes which are differ-
entially regulated by both nutritional insults, with the change in
expression/activity being in the same direction (i.e. up- or down-
regulated in response to both insults). This experimental approach
could be enhanced by the use of DNA methylation arrays or deep
sequencing to explore whether gatekeeper processes are inﬂu-
enced by modiﬁcations to the epigenome.
The suggested approach for identiﬁcation of gatekeeper pro-
cesses has a number of associated problems. It is likely, for exam-
ple, that up- or down-regulation of a fundamental process such as
regulation of the cell cycle might have a profound effect even if the
disturbance was extremely short-lived. Thus the point in gestation
at which analysis is performed will be a critical issue. A further
complication is introduced when considering where the gene
changes may be located. The pattern of gene expression will varyFig. 1. The gatekeeper hypothesis. The ﬁgure shows a Venn diagram of the genes
and pathways altered by different nutritional stresses. Within each pattern is an
overlap outlined in the shaded area, and we hypothesise that these common genes
are the ones that are responsible for generating the phenotype.between different tissues, so it would be expected that the changes
initiated by a nutritional stress could be different in different or-
gans. The timeframe of vulnerability may also differ between or-
gans depending upon their relative rate of maturation and the
differences in onset of organogenesis. Additionally, changes in gene
expression as a consequence of nutritional stress tend to be rela-
tively mild. This is a problem for interpretation, since array and
similar technologies are not usually very sensitive. The difﬁculties
can be minimised by robust statistical analysis and careful exper-
iment design.
Importantly, it may not be identical genes that are affected by
the stress in each modality. Instead, it may be that different genes
along the same pathway, or impacting on the same basic process,
may be altered. Thus, examination of the data sets using pathway
analysis software is essential. Currently, we are testing the hypoth-
esis using two nutritional stressors (protein and iron restriction)
but hope to add further gene sets as they become available.Conclusion
The observation that there is commonality in the long-term
programming response to a diverse range of nutritional insults in
pregnancy provides an important opportunity to determine the
common fundamental biological processes which underpin the
developmental origins of adult disease. The challenge, of course,
is to design appropriate experimental approaches to elucidate
the relevant processes!Conﬂicts of interest
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